Loading...
Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets
As treatment protocols for medulloblastoma (MB) are becoming subgroup-specific, means for reliably distinguishing between its subgroups are a timely need. Currently available methods include immunohistochemical stains, which are subjective and often inconclusive, and molecular techniques—e.g., NanoS...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8223061/ https://ncbi.nlm.nih.gov/pubmed/34178626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.637482 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|